Cataract Surgery with Alcon's AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence Seite 1
09.09.2023 - Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with ... Seite 1
Source: wallstreet-online.de